LumaCyte

LumaCyte is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary technology utilizes Laser Force CytologyTM (LFCTM) to measure optical and fluidic forces within a microfluidic channel to identify and measure the intrinsic cellular properties of each cell. The multivariate nature of the data has enabled a host of Big Data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell based biological systems. Applications of LumaCytes label-free platform technology include viral infectivity for...

Cancer biology,vaccine development,rapid viral infectivity,biomanufacturing,bioprocess monitoring ,oncolytic virus,cell therapy,gene therapy,ipscs,vaccine r&d,vaccine production monitoring,label-free single cell analysis,biomarker identification and monitoring,car t ,aav transfection monitoring,t-cell activation,cmc production quality,transforming the status quo,and rapid viral quantification

Lumacyte operates in the Pharmaceutical manufacturing industry.

Lumacyte's revenue is 11m - 100m

Lumacyte has 11 - 50 employees.